Earnings Outlook For Syros Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Syros Pharmaceuticals (NASDAQ:SYRS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-1.13. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $3.65, down 61.07% over the last 52-week period.
August 07, 2023 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Syros Pharmaceuticals is expected to report an EPS of $-1.13. The company's stock price has historically been affected by earnings reports. The stock is currently down 61.07% over the last 52 weeks.
The company's stock price has historically been affected by its earnings reports. Given the negative trend in the stock price over the past year, the upcoming earnings report could further impact the stock negatively if the company does not meet or exceed the estimated EPS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100